Becton Dickinson & Co (BDX): Shareholders' Equity
$25.39B
As of 2025-09-30
$24.42B
As of 2026-06-30
+0.1%
3-year compound annual growth
+1.3%
5-year compound annual growth
+13.5%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $25.39B | -1.9% | 2025-11-25, Balance as of period end |
| 2024-09-30 | $25.89B | +0.4% | 2025-11-25, Balance as of period end |
| 2023-09-30 | $25.80B | +2.0% | 2024-11-27, Balance as of period end |
| 2022-09-30 | $25.28B | +6.8% | 2023-11-21, Balance as of period end |
| 2021-09-30 | $23.68B | -0.4% | 2022-11-22, Balance as of period end |
| 2020-09-30 | $23.77B | +12.7% | 2021-11-24, Balance as of period end |
| 2019-09-30 | $21.08B | +0.4% | 2020-11-25, Balance as of period end |
| 2018-09-30 | $20.99B | +62.1% | 2019-11-27, Balance as of period end |
| 2017-09-30 | $12.95B | +69.6% | 2018-11-21, Balance as of period end |
| 2016-09-30 | $7.63B | +6.5% | 2017-11-22, Balance as of period end |
| 2015-09-30 | $7.16B | +41.8% | 2016-11-23, Balance as of period end |
| 2014-09-30 | $5.05B | +0.2% | 2015-11-25, Balance as of period end |
| 2013-09-30 | $5.04B | +21.9% | 2014-11-26, Balance as of period end |
| 2012-09-30 | $4.14B | -14.3% | 2013-11-27, Balance as of period end |
| 2011-09-30 | $4.83B | -11.2% | 2012-11-21, Balance as of period end |
| 2010-09-30 | $5.43B | +5.7% | 2011-11-23, Balance as of period end |
| 2009-09-30 | $5.14B | +4.2% | 2010-11-24, Balance as of period end |
| 2008-09-30 | $4.94B | n/a | 2010-01-21, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Becton Dickinson & Co (BDX) | 2025-09-30 | $25.39B | -1.9% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $24.47B | +11.2% |
| 3M Co (MMM) | 2025-12-31 | $4.75B | +21.9% |
| Stryker Corp (SYK) | 2025-12-31 | $22.42B | +8.7% |
| Medline Inc. (MDLN) | 2025-12-31 | $10.74B | n/a |
| Baxter International Inc (BAX) | 2025-12-31 | $6.10B | -13.1% |
| Solventum Corp (SOLV) | 2025-12-31 | $5.05B | +70.6% |
| ResMed Inc (RMD) | 2026-06-30 | $6.59B | +10.3% |
| Dexcom Inc (DXCM) | 2025-12-31 | $2.75B | +30.6% |
Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗